Prot #GRN-1201-002: A Pilot, Open-Label, Multi-Center, Multi-Dose Study of GRN-1201 Added to Pembrolizumab in Subjects with PD-L1+ Non-Small Cell Lung Cancer

  • Villaflor, Victoria Meucci (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date8/1/188/1/21

Funding

  • ICON Clinical Research, LLC (Prot #GRN-1201-002)
  • BrightPath Biotherapeutics Co., Ltd. (Prot #GRN-1201-002)